Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Embolization Particles – Drug Eluting Beads
1.2.3 Polyvinyl Alcohol Particles
1.2.4 Microspheres
1.2.5 Gelatin-Based Embolization Devices
1.2.6 Selective Internal Radiation Therapy
1.2.7 Holmium-Based Microspheres
1.2.8 Liquid Embolics – Onyx
1.2.9 Other
1.3 Market by Application
1.3.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Perspective (2018-2033)
2.2 Novel Drug Delivery Systems for Cancer Therapy Growth Trends by Region
2.2.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Novel Drug Delivery Systems for Cancer Therapy Historic Market Size by Region (2018-2023)
2.2.3 Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Region (2024-2033)
2.3 Novel Drug Delivery Systems for Cancer Therapy Market Dynamics
2.3.1 Novel Drug Delivery Systems for Cancer Therapy Industry Trends
2.3.2 Novel Drug Delivery Systems for Cancer Therapy Market Drivers
2.3.3 Novel Drug Delivery Systems for Cancer Therapy Market Challenges
2.3.4 Novel Drug Delivery Systems for Cancer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Novel Drug Delivery Systems for Cancer Therapy Players by Revenue
3.1.1 Global Top Novel Drug Delivery Systems for Cancer Therapy Players by Revenue (2018-2023)
3.1.2 Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Novel Drug Delivery Systems for Cancer Therapy Revenue
3.4 Global Novel Drug Delivery Systems for Cancer Therapy Market Concentration Ratio
3.4.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Novel Drug Delivery Systems for Cancer Therapy Revenue in 2022
3.5 Novel Drug Delivery Systems for Cancer Therapy Key Players Head office and Area Served
3.6 Key Players Novel Drug Delivery Systems for Cancer Therapy Product Solution and Service
3.7 Date of Enter into Novel Drug Delivery Systems for Cancer Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Novel Drug Delivery Systems for Cancer Therapy Breakdown Data by Type
4.1 Global Novel Drug Delivery Systems for Cancer Therapy Historic Market Size by Type (2018-2023)
4.2 Global Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Type (2024-2033)
5 Novel Drug Delivery Systems for Cancer Therapy Breakdown Data by Application
5.1 Global Novel Drug Delivery Systems for Cancer Therapy Historic Market Size by Application (2018-2023)
5.2 Global Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Novel Drug Delivery Systems for Cancer Therapy Market Size (2018-2033)
6.2 North America Novel Drug Delivery Systems for Cancer Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2018-2023)
6.4 North America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Novel Drug Delivery Systems for Cancer Therapy Market Size (2018-2033)
7.2 Europe Novel Drug Delivery Systems for Cancer Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2018-2023)
7.4 Europe Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size (2018-2033)
8.2 Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size (2018-2033)
9.2 Latin America Novel Drug Delivery Systems for Cancer Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2018-2023)
9.4 Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size (2018-2033)
10.2 Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Advanced Medical Isotope Corporation
11.1.1 Advanced Medical Isotope Corporation Company Detail
11.1.2 Advanced Medical Isotope Corporation Business Overview
11.1.3 Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy Introduction
11.1.4 Advanced Medical Isotope Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
11.1.5 Advanced Medical Isotope Corporation Recent Development
11.2 Bind Therapeutics
11.2.1 Bind Therapeutics Company Detail
11.2.2 Bind Therapeutics Business Overview
11.2.3 Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy Introduction
11.2.4 Bind Therapeutics Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
11.2.5 Bind Therapeutics Recent Development
11.3 Boston Scientific Corporation
11.3.1 Boston Scientific Corporation Company Detail
11.3.2 Boston Scientific Corporation Business Overview
11.3.3 Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy Introduction
11.3.4 Boston Scientific Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
11.3.5 Boston Scientific Corporation Recent Development
11.4 BTG plc
11.4.1 BTG plc Company Detail
11.4.2 BTG plc Business Overview
11.4.3 BTG plc Novel Drug Delivery Systems for Cancer Therapy Introduction
11.4.4 BTG plc Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
11.4.5 BTG plc Recent Development
11.5 CeloNova BioSciences, Inc.
11.5.1 CeloNova BioSciences, Inc. Company Detail
11.5.2 CeloNova BioSciences, Inc. Business Overview
11.5.3 CeloNova BioSciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
11.5.4 CeloNova BioSciences, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
11.5.5 CeloNova BioSciences, Inc. Recent Development
11.6 Cook Medical, Inc.
11.6.1 Cook Medical, Inc. Company Detail
11.6.2 Cook Medical, Inc. Business Overview
11.6.3 Cook Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
11.6.4 Cook Medical, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
11.6.5 Cook Medical, Inc. Recent Development
11.7 Cospheric LLC
11.7.1 Cospheric LLC Company Detail
11.7.2 Cospheric LLC Business Overview
11.7.3 Cospheric LLC Novel Drug Delivery Systems for Cancer Therapy Introduction
11.7.4 Cospheric LLC Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
11.7.5 Cospheric LLC Recent Development
11.8 Covidien, plc
11.8.1 Covidien, plc Company Detail
11.8.2 Covidien, plc Business Overview
11.8.3 Covidien, plc Novel Drug Delivery Systems for Cancer Therapy Introduction
11.8.4 Covidien, plc Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
11.8.5 Covidien, plc Recent Development
11.9 Eckert & Ziegler BEBIG
11.9.1 Eckert & Ziegler BEBIG Company Detail
11.9.2 Eckert & Ziegler BEBIG Business Overview
11.9.3 Eckert & Ziegler BEBIG Novel Drug Delivery Systems for Cancer Therapy Introduction
11.9.4 Eckert & Ziegler BEBIG Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
11.9.5 Eckert & Ziegler BEBIG Recent Development
11.10 EmboMedics, Inc.
11.10.1 EmboMedics, Inc. Company Detail
11.10.2 EmboMedics, Inc. Business Overview
11.10.3 EmboMedics, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
11.10.4 EmboMedics, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
11.10.5 EmboMedics, Inc. Recent Development
11.11 Kobo Products, Inc.
11.11.1 Kobo Products, Inc. Company Detail
11.11.2 Kobo Products, Inc. Business Overview
11.11.3 Kobo Products, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
11.11.4 Kobo Products, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
11.11.5 Kobo Products, Inc. Recent Development
11.12 Merit Medical Systems, Inc.
11.12.1 Merit Medical Systems, Inc. Company Detail
11.12.2 Merit Medical Systems, Inc. Business Overview
11.12.3 Merit Medical Systems, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
11.12.4 Merit Medical Systems, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
11.12.5 Merit Medical Systems, Inc. Recent Development
11.13 Mo-Sci Corporation
11.13.1 Mo-Sci Corporation Company Detail
11.13.2 Mo-Sci Corporation Business Overview
11.13.3 Mo-Sci Corporation Novel Drug Delivery Systems for Cancer Therapy Introduction
11.13.4 Mo-Sci Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
11.13.5 Mo-Sci Corporation Recent Development
11.14 Nanobiotix
11.14.1 Nanobiotix Company Detail
11.14.2 Nanobiotix Business Overview
11.14.3 Nanobiotix Novel Drug Delivery Systems for Cancer Therapy Introduction
11.14.4 Nanobiotix Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
11.14.5 Nanobiotix Recent Development
11.15 Polysciences, Inc.
11.15.1 Polysciences, Inc. Company Detail
11.15.2 Polysciences, Inc. Business Overview
11.15.3 Polysciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
11.15.4 Polysciences, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
11.15.5 Polysciences, Inc. Recent Development
11.16 Sirtex Medical, Inc.
11.16.1 Sirtex Medical, Inc. Company Detail
11.16.2 Sirtex Medical, Inc. Business Overview
11.16.3 Sirtex Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction
11.16.4 Sirtex Medical, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
11.16.5 Sirtex Medical, Inc. Recent Development
11.17 Terumo Corporation
11.17.1 Terumo Corporation Company Detail
11.17.2 Terumo Corporation Business Overview
11.17.3 Terumo Corporation Novel Drug Delivery Systems for Cancer Therapy Introduction
11.17.4 Terumo Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
11.17.5 Terumo Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Embolization Particles – Drug Eluting Beads
Table 3. Key Players of Polyvinyl Alcohol Particles
Table 4. Key Players of Microspheres
Table 5. Key Players of Gelatin-Based Embolization Devices
Table 6. Key Players of Selective Internal Radiation Therapy
Table 7. Key Players of Holmium-Based Microspheres
Table 8. Key Players of Liquid Embolics – Onyx
Table 9. Key Players of Other
Table 10. Global Novel Drug Delivery Systems for Cancer Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 12. Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 13. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Region (2018-2023)
Table 14. Global Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 15. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Region (2024-2033)
Table 16. Novel Drug Delivery Systems for Cancer Therapy Market Trends
Table 17. Novel Drug Delivery Systems for Cancer Therapy Market Drivers
Table 18. Novel Drug Delivery Systems for Cancer Therapy Market Challenges
Table 19. Novel Drug Delivery Systems for Cancer Therapy Market Restraints
Table 20. Global Novel Drug Delivery Systems for Cancer Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 21. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Players (2018-2023)
Table 22. Global Top Novel Drug Delivery Systems for Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Drug Delivery Systems for Cancer Therapy as of 2022)
Table 23. Ranking of Global Top Novel Drug Delivery Systems for Cancer Therapy Companies by Revenue (US$ Million) in 2022
Table 24. Global 5 Largest Players Market Share by Novel Drug Delivery Systems for Cancer Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Novel Drug Delivery Systems for Cancer Therapy Product Solution and Service
Table 27. Date of Enter into Novel Drug Delivery Systems for Cancer Therapy Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 30. Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share by Type (2018-2023)
Table 31. Global Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 32. Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share by Type (2024-2033)
Table 33. Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 34. Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share by Application (2018-2023)
Table 35. Global Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 36. Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share by Application (2024-2033)
Table 37. North America Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Europe Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Europe Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 43. Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 44. Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 45. Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 46. Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 48. Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 49. Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 50. Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 51. Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 52. Advanced Medical Isotope Corporation Company Detail
Table 53. Advanced Medical Isotope Corporation Business Overview
Table 54. Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy Product
Table 55. Advanced Medical Isotope Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023) & (US$ Million)
Table 56. Advanced Medical Isotope Corporation Recent Development
Table 57. Bind Therapeutics Company Detail
Table 58. Bind Therapeutics Business Overview
Table 59. Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy Product
Table 60. Bind Therapeutics Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023) & (US$ Million)
Table 61. Bind Therapeutics Recent Development
Table 62. Boston Scientific Corporation Company Detail
Table 63. Boston Scientific Corporation Business Overview
Table 64. Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy Product
Table 65. Boston Scientific Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023) & (US$ Million)
Table 66. Boston Scientific Corporation Recent Development
Table 67. BTG plc Company Detail
Table 68. BTG plc Business Overview
Table 69. BTG plc Novel Drug Delivery Systems for Cancer Therapy Product
Table 70. BTG plc Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023) & (US$ Million)
Table 71. BTG plc Recent Development
Table 72. CeloNova BioSciences, Inc. Company Detail
Table 73. CeloNova BioSciences, Inc. Business Overview
Table 74. CeloNova BioSciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Product
Table 75. CeloNova BioSciences, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023) & (US$ Million)
Table 76. CeloNova BioSciences, Inc. Recent Development
Table 77. Cook Medical, Inc. Company Detail
Table 78. Cook Medical, Inc. Business Overview
Table 79. Cook Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Product
Table 80. Cook Medical, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023) & (US$ Million)
Table 81. Cook Medical, Inc. Recent Development
Table 82. Cospheric LLC Company Detail
Table 83. Cospheric LLC Business Overview
Table 84. Cospheric LLC Novel Drug Delivery Systems for Cancer Therapy Product
Table 85. Cospheric LLC Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023) & (US$ Million)
Table 86. Cospheric LLC Recent Development
Table 87. Covidien, plc Company Detail
Table 88. Covidien, plc Business Overview
Table 89. Covidien, plc Novel Drug Delivery Systems for Cancer Therapy Product
Table 90. Covidien, plc Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023) & (US$ Million)
Table 91. Covidien, plc Recent Development
Table 92. Eckert & Ziegler BEBIG Company Detail
Table 93. Eckert & Ziegler BEBIG Business Overview
Table 94. Eckert & Ziegler BEBIG Novel Drug Delivery Systems for Cancer Therapy Product
Table 95. Eckert & Ziegler BEBIG Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023) & (US$ Million)
Table 96. Eckert & Ziegler BEBIG Recent Development
Table 97. EmboMedics, Inc. Company Detail
Table 98. EmboMedics, Inc. Business Overview
Table 99. EmboMedics, Inc. Novel Drug Delivery Systems for Cancer Therapy Product
Table 100. EmboMedics, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023) & (US$ Million)
Table 101. EmboMedics, Inc. Recent Development
Table 102. Kobo Products, Inc. Company Detail
Table 103. Kobo Products, Inc. Business Overview
Table 104. Kobo Products, Inc. Novel Drug Delivery Systems for Cancer Therapy Product
Table 105. Kobo Products, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023) & (US$ Million)
Table 106. Kobo Products, Inc. Recent Development
Table 107. Merit Medical Systems, Inc. Company Detail
Table 108. Merit Medical Systems, Inc. Business Overview
Table 109. Merit Medical Systems, Inc. Novel Drug Delivery Systems for Cancer Therapy Product
Table 110. Merit Medical Systems, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023) & (US$ Million)
Table 111. Merit Medical Systems, Inc. Recent Development
Table 112. Mo-Sci Corporation Company Detail
Table 113. Mo-Sci Corporation Business Overview
Table 114. Mo-Sci Corporation Novel Drug Delivery Systems for Cancer Therapy Product
Table 115. Mo-Sci Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023) & (US$ Million)
Table 116. Mo-Sci Corporation Recent Development
Table 117. Nanobiotix Company Detail
Table 118. Nanobiotix Business Overview
Table 119. Nanobiotix Novel Drug Delivery Systems for Cancer Therapy Product
Table 120. Nanobiotix Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023) & (US$ Million)
Table 121. Nanobiotix Recent Development
Table 122. Polysciences, Inc. Company Detail
Table 123. Polysciences, Inc. Business Overview
Table 124. Polysciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Product
Table 125. Polysciences, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023) & (US$ Million)
Table 126. Polysciences, Inc. Recent Development
Table 127. Sirtex Medical, Inc. Company Detail
Table 128. Sirtex Medical, Inc. Business Overview
Table 129. Sirtex Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Product
Table 130. Sirtex Medical, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023) & (US$ Million)
Table 131. Sirtex Medical, Inc. Recent Development
Table 132. Terumo Corporation Company Detail
Table 133. Terumo Corporation Business Overview
Table 134. Terumo Corporation Novel Drug Delivery Systems for Cancer Therapy Product
Table 135. Terumo Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023) & (US$ Million)
Table 136. Terumo Corporation Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Novel Drug Delivery Systems for Cancer Therapy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Type: 2022 VS 2033
Figure 3. Embolization Particles – Drug Eluting Beads Features
Figure 4. Polyvinyl Alcohol Particles Features
Figure 5. Microspheres Features
Figure 6. Gelatin-Based Embolization Devices Features
Figure 7. Selective Internal Radiation Therapy Features
Figure 8. Holmium-Based Microspheres Features
Figure 9. Liquid Embolics – Onyx Features
Figure 10. Other Features
Figure 11. Global Novel Drug Delivery Systems for Cancer Therapy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 12. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Application: 2022 VS 2033
Figure 13. Hospitals Case Studies
Figure 14. Clinics Case Studies
Figure 15. Others Case Studies
Figure 16. Novel Drug Delivery Systems for Cancer Therapy Report Years Considered
Figure 17. Global Novel Drug Delivery Systems for Cancer Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 18. Global Novel Drug Delivery Systems for Cancer Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 19. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Region: 2022 VS 2033
Figure 20. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Players in 2022
Figure 21. Global Top Novel Drug Delivery Systems for Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Drug Delivery Systems for Cancer Therapy as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Novel Drug Delivery Systems for Cancer Therapy Revenue in 2022
Figure 23. North America Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. North America Novel Drug Delivery Systems for Cancer Therapy Market Share by Country (2018-2033)
Figure 25. United States Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe Novel Drug Delivery Systems for Cancer Therapy Market Share by Country (2018-2033)
Figure 29. Germany Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Share by Region (2018-2033)
Figure 37. China Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Japan Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. South Korea Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Southeast Asia Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. India Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Australia Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Latin America Novel Drug Delivery Systems for Cancer Therapy Market Share by Country (2018-2033)
Figure 45. Mexico Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Brazil Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Share by Country (2018-2033)
Figure 49. Turkey Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Saudi Arabia Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Advanced Medical Isotope Corporation Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
Figure 52. Bind Therapeutics Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
Figure 53. Boston Scientific Corporation Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
Figure 54. BTG plc Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
Figure 55. CeloNova BioSciences, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
Figure 56. Cook Medical, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
Figure 57. Cospheric LLC Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
Figure 58. Covidien, plc Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
Figure 59. Eckert & Ziegler BEBIG Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
Figure 60. EmboMedics, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
Figure 61. Kobo Products, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
Figure 62. Merit Medical Systems, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
Figure 63. Mo-Sci Corporation Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
Figure 64. Nanobiotix Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
Figure 65. Polysciences, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
Figure 66. Sirtex Medical, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
Figure 67. Terumo Corporation Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed